Early Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal Metastasis

Peritoneal metastasis (PM) is an advanced stage malignancy largely refractory to modern therapy. Intraperitoneal (IP) immunotherapy offers a novel approach for the control of regional disease of the peritoneal cavity by breaking immune tolerance. These strategies include heightening T-cell response...

Descripción completa

Detalles Bibliográficos
Autores principales: Thadi, Anusha, Khalili, Marian, Morano, William F., Richard, Scott D., Katz, Steven C., Bowne, Wilbur B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160982/
https://www.ncbi.nlm.nih.gov/pubmed/30103457
http://dx.doi.org/10.3390/vaccines6030054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160982/
https://www.ncbi.nlm.nih.gov/pubmed/30103457
http://dx.doi.org/10.3390/vaccines6030054

Ejemplares similares